Van Snick et al., 1985 - Google Patents
A neomycin‐resistant cell line for improved production of monoclonal antibodies to cell surface antigensVan Snick et al., 1985
- Document ID
- 4173196627242842066
- Author
- Van Snick J
- De Plaen E
- Boon T
- Publication year
- Publication venue
- European journal of immunology
External Links
Snippet
Overgrowth of hybridomas by proliferating spleen T cells often hinders the production of monoclonal antibodies to certain antigens. To overcome this problem we derived neomycin‐ resistant fusion partner SP2neoR. l by transfection of SP2/0‐Agl4 cells with plasmid pSVTK …
- 210000004027 cells 0 title abstract description 45
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4350683A (en) | Antibody production from hybrid cell line | |
Mayer et al. | Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation. | |
EP0790309B1 (en) | Cytotoxic lymphocyte maturation factor 40kD subunit and monoclonal antibodies directed thereto | |
EP0182467B1 (en) | Human hybridoma fusion partner for production of human monoclonal antibodies | |
US4594325A (en) | High fusion frequency fusible lymphoblastoid cell line | |
CA1315715C (en) | Human cell line and triomas, antibodies, and transformants derived therefrom | |
US4504586A (en) | Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1 | |
EP0525005B1 (en) | Method for inhibiting cell growth and compositions useful therefor | |
IE61773B1 (en) | Novel lymphokine related peptides | |
JPH0471520B2 (en) | ||
US5114847A (en) | Process for the production of permanently culturable animal and human cell lines and the use thereof | |
Harris et al. | Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6 | |
US5126259A (en) | Human b. lymphoblastoid cell, hybridoma, antibody and production of antibody | |
Dardenne et al. | Monoclonal antibody against the serum thymic factor (FTS) | |
Sharon et al. | Formation of hybridoma clones in soft agarose: effect of pH and of medium | |
GB2134134A (en) | Novel cell lines for use in the preparation of hybridoma cells | |
Ralph et al. | Functions of macrophage cell lines | |
Van Snick et al. | A neomycin‐resistant cell line for improved production of monoclonal antibodies to cell surface antigens | |
CA1330768C (en) | Monoclonal anti-human granulocyte colony stimulating factor antibody | |
US5192684A (en) | Human IgG1 monoclonal antibody specific for the nicotinic acetylcholine receptor and hybridoma producing the antibody | |
EP0289252B1 (en) | Anti-T cell receptor gamma-chain monoclonal antibody | |
Barnum et al. | Biosynthesis of complement protein D by HepG2 cells: a comparison of D produced by HepG2 cells, U937 cells and blood monocytes | |
Rathjen et al. | Conditioned medium from macrophage cell lines supports the single-cell growth of hybridomas | |
EP0251106A2 (en) | Improved fusion method | |
CA1218947A (en) | Human hybrid cell lines |